Plain-English translation of NCT06392711 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing mesenchymal stromal cells (MSCs)—a type of stem cell—as a treatment for severe dry mouth that happens because of autoimmune diseases like Sjögren's disease or as a side effect of cancer treatments. Researchers will inject these cells directly into your salivary glands to see if the medication can help restore moisture to your mouth and whether it is safe to use.
Severe dry mouth can seriously impact quality of life, making it hard to eat, speak, and sleep. Current treatments are limited, so this trial is exploring whether stem cell therapy could offer patients a new option to help their salivary glands work again.
You likely qualify if…
You likely don't qualify if…
You will first undergo screening tests to confirm you qualify, including blood work and salivary flow measurements. Then you'll have a bone marrow aspiration, a procedure where doctors take a small sample of bone marrow to extract the stem cells. Finally, you'll receive injections of the stem cells directly into one or both of your salivary glands under local anesthesia. You'll return for follow-up visits so researchers can monitor your safety and measure whether your dry mouth improves.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States